Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibacterial Activity of Boswellia Sacra Extract Against P. Gingivalis
NCT04705714Phase 1Completed
- Sponsor
- Tanta University
- Start
- Jan 2021
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Boswellia sacra oleoresin extract in periodontitis, sponsored by Tanta University. Primary endpoint: Isolation of P. gingivalis at Day 0. Started Jan 2021; status: completed.
02
Drugs
Boswellia sacra oleoresin extract
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT04705714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04705714.